|
United Therapeutics Corporation - Company Profile Snapshot
| Company Profile: |
United Therapeutics Corporation |
| Ticker: |
UTHR |
| Exchanges: |
NAS |
| 2008 Sales: |
281,500,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
UNITED STATES |
| Employees: |
360 |
Business Description
United Therapeutics Corporation. The Group's principal activity is to focus on the development and commercialization of unique products for patients with chronic and life-threatening diseases. It operates in two segments: Pharmaceuticals and Telemedicine. The Pharmaceutical segment includes all activities associated with the research, development, manufacture and commercialization of therapeutic products. The Telemedicine segment includes all activities associated with the research, design and delivery of patient monitoring services. The Group also focuses on the development of glycobiology antiviral agents for the treatment of hepatitis and other diseases. It operates in the United States and other countries.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
